Between-hospital care referrals for severe alcohol-related liver disease during the COVID-19 pandemic, 2020 to 2022
Alcohol and Alcoholism · 2024
DOI: 10.1093/alcalc/agad071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol and Alcoholism, 2024. Verfasst von Erik Almazan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, MD, United States. Hauptthemen laut MEDLINE: Liver Diseases, Alcoholic, COVID-19. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health, Gilead Sciences Research Scholars Program in Liver Disease-The Americas.
Abstract (Originalsprache)
Increased alcohol consumption during the coronavirus disease 2019 pandemic is projected to impact alcohol-related liver disease (ALD) morbidity and mortality. Inter-hospital escalation-of-care referral requests to our tertiary-care hepatology unit were analyzed from January 2020 through December 2022. Most requests to our center were for ALD with an increase in requests from intermediate care units, suggestive of higher acuity illness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Care Management, Johns Hopkins Hospital, Baltimore, MD, United States.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Division of Gastroenterology & Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health
- Gilead Sciences Research Scholars Program in Liver Disease-The Americas
- National Institute on Alcohol Abuse and Alcoholism
- National Institutes of Health
- Gilead Sciences Research Scholars Program in Liver Disease—The Americas
Zitieren
APA
Almazan, E., Dixon, J., Gerstenblith, A., Andrews, S., Flanary, J., Cameron, A. M., Gurakar, A., & Chen, P. H. (2024). Between-hospital care referrals for severe alcohol-related liver disease during the COVID-19 pandemic, 2020 to 2022. Alcohol and Alcoholism. https://doi.org/10.1093/alcalc/agad071
Vancouver
Almazan E, Dixon J, Gerstenblith A, Andrews S, Flanary J, Cameron AM, et al. Between-hospital care referrals for severe alcohol-related liver disease during the COVID-19 pandemic, 2020 to 2022. Alcohol and Alcoholism. 2024. doi:10.1093/alcalc/agad071
BibTeX
@article{Almazan2024,
author = {Almazan, Erik and Dixon, Juliette and Gerstenblith, Avi and Andrews, Sarah and Flanary, James and Cameron, Andrew M and Gurakar, Ahmet and Chen, Po-Hung},
title = {Between-hospital care referrals for severe alcohol-related liver disease during the COVID-19 pandemic, 2020 to 2022},
journal = {Alcohol and Alcoholism},
year = {2024},
doi = {10.1093/alcalc/agad071}
}
EUVIMED